Farma

BenteBazooka
07.12.2018 kl 13:28 3226

Jeg håper også at blc for surveillance blir inkludert neste gang, både NCCN og aua. Jeg tror NCCN oppdaterer guidelines sine en gang i året, i motsetning til AUA som oppdaterer de ganske sjeldent.

NCCN har forøvrig en annen gradering enn AUA:
NCCN Categories of Evidence and Consensus
Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2A: Based upon lower-level evidence, there is uniform NCCN consensus that the intervention is appropriate.
Category 2B: Based upon lower-level evidence, there is NCCN consensus that the intervention is appropriate.
Category 3: Based upon any level of evidence, there is major NCCN disagreement that the intervention is appropriate.
All recommendations are category 2A unless otherwise indicated.

AUA:
By definition, Grade A evidence is evidence about which the Panel has a high level of certainty, Grade B evidence is evidence about which the Panel has a moderate level of certainty, and Grade C evidence is evidence about which the Panel has a low level of certainty. The 38 statements created vary in level of evidence, but none include Level A evidence, and a majority are Level C evidence.


Dataene de nå har bør være solide nok til en bedre anbefaling, ivertfall for TURBT.
"The publication is on results from a Prospective Multicenter Registry Study that is the largest Bladder Cancer Registry Study ever done in the US"

"It has been very exciting to see the on-going increase in real world data as a result of this registry study. This publication based on data collected from 2014 to 2016, 9 referral sites, 1632 samples and 533 patients, show that the combination of White Light and Blue Light with Cysview increased the detection on papillary disease by 12%, CIS lesions by 43% and most importantly, resulted in change of management in 14% of patients. This means that patients are staged more accurately, which is very likely to impact their outcomes"
https://www.cysview.com/news/positive-results-from-blc-with-cysview-r-registry-published-in-the-urologic-oncology-journal
Redigert 07.12.2018 kl 13:32

Rapportér innlegg

Vennligst skriv inn kommentar på hva du mener er upassende og trykk send. Dersom kommentar ikke er nødvendig, vennligst trykk send direkte.
E-postadressen brukes kun for å få kontakt med deg i forbindelse med advarselen.
E-postadressen brukes kun for å få kontakt med deg i forbindelse med advarselen.